Skip to main content
MindWalk Holdings Corp. logo

MindWalk Holdings Corp. — Investor Relations & Filings

Ticker · HYFT ISIN · CA45257F2008 US Professional, scientific and technical activities
Open in API
Filings indexed 256 across all filing types
Latest filing 2021-01-06 Regulatory Filings
Country US United States of America
Listing US HYFT

About MindWalk Holdings Corp.

https://www.ipatherapeutics.com/

MindWalk Holdings Corp. is a Bio-Native AI company that focuses on transforming drug discovery and development. The company operates a biointelligence ecosystem that integrates artificial intelligence, multi-omics data, and advanced laboratory research to make complex biology computable and actionable. This unified platform is designed to accelerate the discovery and development of biologics, including therapeutic antibodies, diagnostics, vaccines, and peptide therapeutics, from target identification through to the clinical stage. Its capabilities are powered by proprietary technologies such as the patented HYFT® technology and the LensAI™ platform, which are adaptable to specific targets, modalities, and program priorities.

Recent filings

Filing Released Lang Actions
IMMUNOPRECISE ANTIBODIES LTD. 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release dated January 6, 2021, but the document length is only 1395 characters, indicating it is a brief announcement rather than a full report. There is no substantive financial data or detailed report content. According to the rules, such short filings that primarily announce or attach other reports or press releases should be classified as Regulatory Filings (RNS).
2021-01-06 English
F-10/A
Capital/Financing Update Classification · 95% confidence The document is a Form F-10/A, which is an amendment to a registration statement filed with the U.S. Securities and Exchange Commission under the Securities Act of 1933. It is a short form base shelf prospectus for ImmunoPrecise Antibodies Ltd., detailing the offering of various securities including common shares, preferred shares, debt securities, warrants, units, and subscription receipts. The document includes detailed information about the securities, terms of the offering, listing information, and regulatory disclosures. This type of filing is related to capital raising and financing activities by the company. It is not an annual report, earnings release, or management discussion, but rather a registration statement for securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual filing, not just an announcement or notice.
2021-01-05 English
IMMUNOPRECISE ANTIBODIES LTD. 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It is not an annual report (like 10-K or 20-F), nor does it contain financial statements or detailed financial data. The document is short (1397 characters) and primarily serves as a regulatory filing to report a press release dated December 30, 2020. There is no substantive financial report or detailed management discussion. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2020-12-30 English
Regulatory Filings 2020
Regulatory Filings
2020-12-29 English
40FR12B/A
Regulatory Filings Classification · 95% confidence The document is a Form 40-F/A (Amendment No. 4) filed with the SEC by ImmunoPrecise Antibodies Ltd., a Canadian issuer. Form 40-F is a registration statement pursuant to Section 12 of the Securities Exchange Act of 1934, used by certain Canadian companies to register securities with the SEC. The document includes detailed disclosures about the company, its governance, contractual obligations, and references to exhibits including financial statements, management discussion and analysis, certifications, and notices of annual general meetings. It is an amendment to a registration statement, not a full annual report or earnings release. The document is regulatory in nature, primarily serving as a filing to update or amend prior registration information. It does not contain full financial statements or detailed financial performance data itself but incorporates such information by reference. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for filings that do not fit other specific categories and includes registration statements and amendments thereto.
2020-12-28 English
Regulatory Filings 2020
Regulatory Filings
2020-12-28 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.